BACKGROUND Fungal keratitis is one of the major cause of visual loss in developing countries. A contributing factor for the development of fungal infection is ocular trauma and contamination of corneal lesions by soil and vegetative material. Another factor being widespread use of broad-spectrum antibiotics, steroids and contact lens wear. According to the World Health Organization report, it is estimated that ocular trauma and corneal ulceration result in 1.5 to 2 million new patients of corneal blindness annually. In India, the incidence of corneal ulceration is reported to be 1130 per million population. Corneal infection of fungal aetiology is common in India (19-45%). Corneal infection of fungal aetiology is very common and may represent 30 to 40% of all cases of culture-positive infectious keratitis in South India.4 more than 70 species of filamentous fungi have been identified as the aetiological agents of fungal keratitis. Of these, Aspergillus and Fusarium are responsible for 70% of cases. The aim of the study is to study the-1. Clinical presentation, contributing and precipitating factors for fungal keratitis and prognosis with regard to the available mode of therapy. 2. Investigations regarding the type of fungus and the statistical significance regarding the common type of fungi that involve the cornea. MATERIALS AND METHODS All cases of keratitis that presented were investigated with KOH wet mount and fungal culture. Histopathological diagnosis was made with the report of fungal culture. All cases of fungal keratitis were treated with antifungal and clinically studied in the Department of Ophthalmology, KIMS, Hubli, from 1 st January, 2016-December 2016. RESULTS In the clinical study of fungal keratitis, out of 62 cases, suppurative keratitis 30(48.38%) cases were fungal keratitis on clinical suspicion and fungal staining.
Combination of two or more active ingredients in a fixed dose ratio is termed as fixed dose combination (FDC). Presently, there is lot of debate over rationality and irrationality of FDCs. This study was focused on medical undergraduates to evaluate the awareness about FDCs as these students are the future practitioners. Like two sides of each coin FDCs do have advantages & disadvantages and it"s up to the physician to misuse it or use it judiciously by maintaining the balance. The objective is to evaluate the awareness of Fixed dose combinations (FDCs) among 2 nd year medical students. A cross-sectional questionnaire-based study was conducted among 2 nd year medical students of AIMS, B G Nagar. Total respondents were 134. Among them 57 participants (42.53%) are male and 77 participants (57.46%) are females. All the participants were within the age group of 19 to 21 years. The analysis of responses for assessing the awareness of students about FDCs, showed that students had a high level of awareness (>80%) regarding some of basic aspects related to FDCs like knowing the term (66.41%), their common use in prescription (67.91%), constitution of FDC (50%), providing benefits to patients by improving compliance (54.47%) and increasing therapeutic response (64.17%). However, students weren"t aware regarding the deeper scientific aspects of FDCs like need for similarity in pharmacokinetics of ingredient drugs (21.64%), rationality & approval status of FDCs available in market. Majority of the students are well aware about the basic concepts of FDCs and their usage; however they are lacking in deeper scientific concepts. It is imperative that the concept of FDCs should be emphasized in sufficient detail to these budding doctors by giving an educational intervention through an interactive lecture presentation; so that the awareness of the students can be increased substantially.
BACKGROUND Control of childhood blindness is one of the priorities identified for achieving the goals of Vision-2020 by WHO. This is considered a priority because blind-years (number of years that a blind person lives after going blind) due to childhood blindness are second only to cataract and half of childhood blindness is avoidable (treatable/preventable). Paediatric cataract accounts for 12% of the 1.4 million blind children globally. The prevalence of childhood cataract has been reported as 1 to 15 cases in 10,000 children in developing countries. Compared to industrialised countries, this figure is 10 times higher. Early detection and timely treatment of various childhood disorders such as congenital cataract are the most crucial factors for successful outcome. A suitable measure to address amblyopia and posterior capsule opacification post operatively is imperative for successful visual rehabilitation of such children. The objectives of this study were-1) To study the clinical profile of paediatric cataract. 2) To evaluate the visual outcome after cataract surgery in these patients. 3) To evaluate different causes of visual impairment following management. MATERIALS AND METHODS A prospective study conducted at Karnataka institute of medical sciences department of ophthalmology from October 2015 to September 2016. All children below 14 years of age presenting with cataract will undergo thorough ophthalmologic examination and cataract surgery. RESULTS The results of the present study with 25 paediatric patients (36 eyes) indicates that excellent vision can be expected after cataract surgery and posterior chamber IOL implantation coupled with appropriate amblyopia therapy. CONCLUSION The paediatric cataract patients are referred from primary health centers, and district hospital from north Karnataka to KIMS Hubli. All paediatric patients are from lower socio economic status. Early detection of cataracts and referrals to the ophthalmologist can result in early treatment and better visual outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.